Winfield Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $374K | Hold |
5,636
| – | – | 0.14% | 117 |
|
2021
Q4 | $328K | Buy |
+5,636
| New | +$328K | 0.11% | 127 |
|
2018
Q1 | – | Sell |
-790
| Closed | -$28K | – | 161 |
|
2017
Q4 | $28K | Buy |
790
+10
| +1% | +$354 | 0.01% | 253 |
|
2017
Q3 | $26K | Hold |
780
| – | – | 0.01% | 254 |
|
2017
Q2 | $27K | Hold |
780
| – | – | 0.01% | 249 |
|
2017
Q1 | $24K | Buy |
780
+270
| +53% | +$8.31K | 0.01% | 244 |
|
2016
Q4 | $14K | Sell |
510
-155
| -23% | -$4.26K | 0.01% | 315 |
|
2016
Q3 | $22K | Sell |
665
-5
| -0.7% | -$165 | 0.01% | 239 |
|
2016
Q2 | $20K | Buy |
670
+10
| +2% | +$299 | 0.01% | 248 |
|
2016
Q1 | $19K | Buy |
+660
| New | +$19K | 0.01% | 240 |
|